Product Description

5-BPDI: Chemical Properties, Uses, Effects & Safety Information

5-BPDI is a synthetic chemical compound that belongs to the broader family of synthetic cathinones. Researchers and forensic laboratories have identified it as 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one, and it is also known by names such as Indanyl-α-PHP.

Because 5-BPDI has psychoactive stimulant properties and limited human safety data, it should not be presented as an approved medicine, dietary supplement, or treatment. Instead, reliable information should focus on its chemical identity, scientific classification, research background, and safety considerations.

What Is 5-BPDI?

5-BPDI is a substituted cathinone derivative with a chemical structure related to other pyrrolidinophenone compounds. Scientific literature has reported 5-BPDI as one of several newly identified synthetic cathinones.

The compound is sometimes described using the name Indanyl-α-PHP. PubChem lists its IUPAC name as 1-(2,3-dihydro-1H-inden-5-yl)-2-pyrrolidin-1-ylhexan-1-one.

Therefore, people researching 5-BPDI should distinguish its scientific identity from claims made by unofficial sources or online sellers.

5-BPDI Chemical Information

The main chemical information currently available includes:

• Common name: 5-BPD
• Alternative name: Indanyl-α-PHP
• IUPAC name: 1-(2,3-dihydro-1H-inden-5-yl)-2-pyrrolidin-1-ylhexan-1-one
• Molecular formula: C₁₉H₂₇NO
• Molecular weight: approximately 285.4 g/mol
• PubChem CID: 132989236
• UNII: AJE4Z9D96B
• InChIKey: WETQQOQCDBNIKE-UHFFFAOYSA-N

Furthermore, PubChem reports a calculated XLogP3-AA value of 4.8 and a topological polar surface area of 20.3 Ų. These are computed chemical properties rather than measurements of medical effectiveness or safety.

Chemical Structure of 5-BPDI

The structure of 5-BPI contains an indanyl-based ring system together with a pyrrolidine-containing side chain. Its molecular structure helps distinguish it from other synthetic cathinones.

The compound has one undefined stereocenter according to the PubChem record, while NCATS describes the registered substance as racemic.

Consequently, chemical identification should rely on analytical methods rather than names alone.

5-BPDI Classification

5-BPD is classified within the broader group of synthetic cathinones. PubChem’s record also connects the substance with DEA drug and chemical information and identifies it under the synthetic cathinone category.

Synthetic cathinones represent a diverse group of compounds with structures related to cathinone. Some members of this group can produce stimulant effects. However, the effects, potency, toxicity, and duration can vary significantly between individual compounds.

What Is 5-BPDI Used For?

5-BPD does not have an established approved therapeutic use. Available records primarily provide chemical identification, forensic information, and scientific research references.

For that reason, it would be inaccurate to describe 5-BDI as a treatment for pain, anxiety, depression, weight loss, ADHD, or another medical condition.

Researchers may study compounds in this chemical family to understand their structures, analytical characteristics, metabolism, and presence in forensic samples. However, laboratory research should not be confused with clinical approval.

5-BPDI Effects and Pharmacology

5-BPI has been described in scientific and reference sources as a stimulant-type synthetic cathinone. However, detailed human pharmacological and clinical information remains limited.

Importantly, limited information does not mean that a substance is safe. In fact, uncertainty can make risk assessment more difficult.

Therefore, there is not enough reliable clinical evidence to establish a therapeutic dose, safe recreational dose, long-term safety profile, or medically recommended administration method for 5-BD.

Safety Information

Safety is particularly important when discussing 5-BPD. The compound is not an approved medicine, and reliable clinical safety information is limited.

Potential risks associated with psychoactive stimulant-type compounds can include unwanted cardiovascular, neurological, psychological, and other adverse effects. The actual risk can depend on factors such as the compound’s purity, concentration, individual physiology, and exposure.

Additionally, products sold under research-chemical names may not always contain the stated compound or concentration. Therefore, product labels alone cannot establish identity, purity, or safety.

Is 5-BPDI FDA Approved?

No evidence in the cited FDA substance record indicates that 5-BPD has received FDA approval as a medicine. The FDA’s Substance Registration System identifies 5-BPD through a UNII record, but the FDA specifically explains that having a UNII does not imply regulatory review or approval.

Thus, an FDA database listing should not be interpreted as evidence that 5-BPI is an approved pharmaceutical.

Legal and Regulatory Considerations

The legal status of 5-BPD can differ between countries and may change over time. PubChem connects the compound with DEA information and records it within the synthetic cathinone category.

Consequently, anyone conducting legitimate laboratory research should check the current laws, institutional requirements, and controlled-substance regulations that apply to their location before handling any psychoactive research chemical.

<h2>5-BPD Research Background

Scientific research has identified 5-BPI among emerging synthetic cathinones. A 2019 forensic toxicology study reported the identification and structural characterization of 5-BPD alongside several other synthetic cathinone compounds.

This research is valuable because new psychoactive substances can appear faster than comprehensive toxicological data becomes available. Analytical studies therefore help laboratories recognize and distinguish newly encountered compounds.

Frequently Asked Questions

What does 5-BPDI stand for?

<p>5-BPDI is the common short name used for 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one, also known as Indanyl-α-PHP.

What is the molecular formula of 5-BPDI?

The molecular formula is C₁₉H₂₇NO, with a molecular weight of approximately 285.4 g/mol</strong>.

Is 5-BPDI a medicine?

No. Available authoritative records do not establish 5-BPDI as an approved medicine.

Is 5-BPDI a synthetic cathinone?

Yes. PubChem classifies 5-BPDI under synthetic cathinones.</p>

Does 5-BPDI have an established medical dosage?

No established therapeutic dosage exists because 5-BPD is not an approved medicine and lacks sufficient clinical evidence.</p>

Why is 5-BPDI studied?

Researchers and forensic laboratories can study compounds such as 5-BPD for chemical identification, structural characterization, analytical detection, and broader research into emerging synthetic cathinones.

Conclusion</h2>

<strong>5-BPD is a synthetic cathinone compound also known as Indanyl-α-PHP. Its scientific identity is well documented, including its molecular formula C₁₉H₂₇NO, molecular weight of approximately 285.4 g/mol, and systematic chemical name.</p>

However, 5-BPDI should not be confused with an approved pharmaceutical or dietary supplement. Human safety and therapeutic evidence remain limited. Therefore, responsible information should focus on its chemical characteristics, research history, classification, and potential safety concerns rather than unsupported health or treatment claims.

Additional Information